5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one

C135H160BrF6N33O14 — CID 163778510

IUPAC5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one
SMILESCCNc1cc2c(cn1)c(-c1ccc(OC3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(-c1ccc(OC3CCOCC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(Br)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1.CNc1cc2c(cn1)c(-c1ccc(C3CCN(CCOC)CC3)nc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1
InChIInChI=1S/C31H40N8O3.C31H39N7O3.C30H36N6O4.C23H24F3N7O2.C20H21BrF3N5O2/c1-32-28-18-27-25(20-34-28)31(22-4-9-26(33-19-22)21-12-14-38(15-13-21)16-17-41-3)36-39(27)23-5-7-24(8-6-23)42-29-10-11-30(40)37(2)35-29;1-4-32-28-19-27-26(20-33-28)31(21-5-9-23(10-6-21)40-25-15-17-36(2)18-16-25)35-38(27)22-7-11-24(12-8-22)41-29-13-14-30(39)37(3)34-29;1-3-31-27-18-26-25(19-32-27)30(20-4-8-22(9-5-20)39-24-14-16-38-17-15-24)34-36(26)21-6-10-23(11-7-21)40-28-12-13-29(37)35(2)33-28;1-27-19-9-17-16(11-28-19)21(13-10-29-32(2)12-13)31-33(17)14-3-5-15(6-4-14)35-18-7-8-20(34)30-22(18)23(24,25)26;1-2-25-16-9-14-13(10-26-16)19(21)28-29(14)11-3-5-12(6-4-11)31-15-7-8-17(30)27-18(15)20(22,23)24/h4,9-11,18-21,23-24H,5-8,12-17H2,1-3H3,(H,32,34);5-6,9-10,13-14,19-20,22,24-25H,4,7-8,11-12,15-18H2,1-3H3,(H,32,33);4-5,8-9,12-13,18-19,21,23-24H,3,6-7,10-11,14-17H2,1-2H3,(H,31,32);7-12,14-15H,3-6H2,1-2H3,(H,27,28)(H,30,34);7-12H,2-6H2,1H3,(H,25,26)(H,27,30)
InChIKeyMMOHHJKPXUHDMM-UHFFFAOYSA-N
MW2662.87 g/mol
LogP22.46
Rot. Bonds35

About 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one

5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one (PubChem CID 163778510) has the molecular formula C135H160BrF6N33O14 and a molecular weight of 2662.87 g/mol. Its IUPAC name is 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one.

Molecular Properties

Compound Name5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one
PubChem CID163778510
Molecular FormulaC135H160BrF6N33O14
Molecular Weight2662.87 g/mol
Exact Mass2660.19
IUPAC Name5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one
SMILESCCNc1cc2c(cn1)c(-c1ccc(OC3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(-c1ccc(OC3CCOCC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(Br)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1.CNc1cc2c(cn1)c(-c1ccc(C3CCN(CCOC)CC3)nc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1
InChIInChI=1S/C31H40N8O3.C31H39N7O3.C30H36N6O4.C23H24F3N7O2.C20H21BrF3N5O2/c1-32-28-18-27-25(20-34-28)31(22-4-9-26(33-19-22)21-12-14-38(15-13-21)16-17-41-3)36-39(27)23-5-7-24(8-6-23)42-29-10-11-30(40)37(2)35-29;1-4-32-28-19-27-26(20-33-28)31(21-5-9-23(10-6-21)40-25-15-17-36(2)18-16-25)35-38(27)22-7-11-24(12-8-22)41-29-13-14-30(39)37(3)34-29;1-3-31-27-18-26-25(19-32-27)30(20-4-8-22(9-5-20)39-24-14-16-38-17-15-24)34-36(26)21-6-10-23(11-7-21)40-28-12-13-29(37)35(2)33-28;1-27-19-9-17-16(11-28-19)21(13-10-29-32(2)12-13)31-33(17)14-3-5-15(6-4-14)35-18-7-8-20(34)30-22(18)23(24,25)26;1-2-25-16-9-14-13(10-26-16)19(21)28-29(14)11-3-5-12(6-4-11)31-15-7-8-17(30)27-18(15)20(22,23)24/h4,9-11,18-21,23-24H,5-8,12-17H2,1-3H3,(H,32,34);5-6,9-10,13-14,19-20,22,24-25H,4,7-8,11-12,15-18H2,1-3H3,(H,32,33);4-5,8-9,12-13,18-19,21,23-24H,3,6-7,10-11,14-17H2,1-2H3,(H,31,32);7-12,14-15H,3-6H2,1-2H3,(H,27,28)(H,30,34);7-12H,2-6H2,1H3,(H,25,26)(H,27,30)
InChIKeyMMOHHJKPXUHDMM-UHFFFAOYSA-N
XLogP22.46
TPSA504.35 Ų
H-Bond Donors7
H-Bond Acceptors45
Rotatable Bonds35
Heavy Atoms189
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002662.87
LogP ≤ 522.46
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1045

Analyze 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one?
The IUPAC name of 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one (CID 163778510) is 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one.
What is the SMILES notation for 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one?
The canonical SMILES for 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one is CCNc1cc2c(cn1)c(-c1ccc(OC3CCN(C)CC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(-c1ccc(OC3CCOCC3)cc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CCNc1cc2c(cn1)c(Br)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1.CNc1cc2c(cn1)c(-c1ccc(C3CCN(CCOC)CC3)nc1)nn2C1CCC(Oc2ccc(=O)n(C)n2)CC1.CNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(=O)[nH]c2C(F)(F)F)CC1.
What is the InChIKey of 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one?
The InChIKey is MMOHHJKPXUHDMM-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H40N8O3.C31H39N7O3.C30H36N6O4.C23H24F3N7O2.C20H21BrF3N5O2/c1-32-28-18-27-25(20-34-28)31(22-4-9-26(33-19-22)21-12-14-38(15-13-21)16-17-41-3)36-39(27)23-5-7-24(8-6-23)42-29-10-11-30(40)37(2)35-29;1-4-32-28-19-27-26(20-33-28)31(21-5-9-23(10-6-21)40-25-15-17-36(2)18-16-25)35-38(27)22-7-11-24(12-8-22)41-29-13-14-30(39)37(3)34-29;1-3-31-27-18-26-25(19-32-27)30(20-4-8-22(9-5-20)39-24-14-16-38-17-15-24)34-36(26)21-6-10-23(11-7-21)40-28-12-13-29(37)35(2)33-28;1-27-19-9-17-16(11-28-19)21(13-10-29-32(2)12-13)31-33(17)14-3-5-15(6-4-14)35-18-7-8-20(34)30-22(18)23(24,25)26;1-2-25-16-9-14-13(10-26-16)19(21)28-29(14)11-3-5-12(6-4-11)31-15-7-8-17(30)27-18(15)20(22,23)24/h4,9-11,18-21,23-24H,5-8,12-17H2,1-3H3,(H,32,34);5-6,9-10,13-14,19-20,22,24-25H,4,7-8,11-12,15-18H2,1-3H3,(H,32,33);4-5,8-9,12-13,18-19,21,23-24H,3,6-7,10-11,14-17H2,1-2H3,(H,31,32);7-12,14-15H,3-6H2,1-2H3,(H,27,28)(H,30,34);7-12H,2-6H2,1H3,(H,25,26)(H,27,30).
What are the key properties of 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one?
5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one has a molecular weight of 2662.87 g/mol, XLogP of 22.46, 35 rotatable bonds, 7 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[3-bromo-6-(ethylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one;6-[4-[6-(ethylamino)-3-[4-(1-methylpiperidin-4-yl)oxyphenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[6-(ethylamino)-3-[4-(oxan-4-yloxy)phenyl]pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;6-[4-[3-[6-[1-(2-methoxyethyl)piperidin-4-yl]-3-pyridinyl]-6-(methylamino)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-2-methylpyridazin-3-one;5-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-6-(trifluoromethyl)-1H-pyridin-2-one is sourced from PubChem (CID 163778510), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).